Table 3.
Spearman Correlation Coefficients P Values Number of Observations | ||||||
---|---|---|---|---|---|---|
LA Volume Index | E/A Ratio | Medial E/e′ (m/sec) | Lateral E/e′ (m/sec) | Relative Wall Thickness | LV Mass | |
PTX3 | 0.41 | 0.18 | 0.02 | −0.16 | 0.08 | 0.26 |
0.002 | 0.196 | 0.872 | 0.165 | 0.523 | 0.042 | |
57 | 53 | 73 | 73 | 60 | 60 | |
IL‐6 | 0.11 | −0.11 | 0.18 | 0.22 | 0.23 | 0.05 |
0.438 | 0.434 | 0.134 | 0.066 | 0.084 | 0.691 | |
57 | 52 | 72 | 72 | 60 | 60 | |
TNF‐α | 0.06 | −0.31 | 0.17 | 0.15 | 0.14 | 0.16 |
0.672 | 0.040 | 0.176 | 0.238 | 0.305 | 0.244 | |
52 | 46 | 65 | 65 | 54 | 54 | |
hs‐CRP | −0.12 | −0.10 | 0.07 | 0.07 | 0.10 | 0.00 |
0.400 | 0.468 | 0.567 | 0.569 | 0.435 | 0.987 | |
55 | 52 | 71 | 71 | 59 | 59 |
hs‐CRP indicates high sensitivity C reactive protein; IL‐6, interleukin 6; LA, left atrial; LV, left ventricular; PTX3, pentraxin 3; RELAX, Effect of Phosphodiesterase‐5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction; TNF‐A, tumor necrosis factor‐α.